Eugene L. Stewart
GlaxoSmithKline (United States) · 78 works · 3,045 citations · h-index 24
Top works
- Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition
- Structural Basis for Androgen Receptor Interdomain and Coactivator Interactions Suggests a Transition in Nuclear Receptor Activation Function Dominance
- A New Series of Estrogen Receptor Modulators That Display Selectivity for Estrogen Receptor β
- X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor−Ligand Binding Domain
- A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor
- A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator
- Ab initio calculations with electronic correlation (MP2) on the nucleic acid bases and their methyl derivatives
- Progesterone Receptor Ligand Binding Pocket Flexibility: Crystal Structures of the Norethindrone and Mometasone Furoate Complexes
- Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors
- 2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor
- The evolution of progesterone receptor ligands
- Structure and Function of the Glucocorticoid Receptor Ligand Binding Domain
- Discovery of Tertiary Sulfonamides as Potent Liver X Receptor Antagonists
- Discovery of non-steroidal mifepristone mimetics: Pyrazoline-based PR antagonists
- Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase
- Molecular Mechanics (MM3) Calculations on Oxygen-Containing Phosphorus (Coordination IV) Compounds
- The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist
- Application of the PharmPrint Methodology to Two Protein Kinases
- Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
- Array synthesis of progesterone receptor antagonists: 3-Aryl-1,2-diazepines